Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct IgM and IgG autoantibody profiles characterize incomplete and classified systemic autoimmune diseases.

Frontiers in immunology·2026
Same author

Persistent CD4<sup>+</sup> T cell hyporesponsiveness during recovery from prolonged symptomatic SARS-CoV-2 infection.

Cellular immunology·2026
Same author

ACLY integrates metabolism and chromatin accessibility to enable B Cell activation and humoral immunity.

bioRxiv : the preprint server for biology·2026
Same author

The Association of Osteoarthritis With De Novo Inflammatory Arthritis in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study.

Arthritis care & research·2026
Same author

Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response.

bioRxiv : the preprint server for biology·2026
Same author

Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.

American journal of respiratory and critical care medicine·2026

Related Experiment Video

Updated: Aug 25, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.9K

A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus.

Melissa E Munroe1, Derek Blankenship2, Daniele DeFreese3

  • 1Progentec Diagnostics, Inc., and Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City.

Arthritis & Rheumatology (Hoboken, N.J.)
|October 17, 2022
PubMed
Summary
This summary is machine-generated.

Researchers identified specific immune mediators that predict imminent flares in Systemic Lupus Erythematosus (SLE). A refined flare risk index (FRI) using these markers accurately identifies patients at risk, aiding proactive management.

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.0K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

528

Related Experiment Videos

Last Updated: Aug 25, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.9K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.0K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

528

Area of Science:

  • Immunology
  • Rheumatology
  • Biomarker Discovery

Background:

  • Systemic lupus erythematosus (SLE) is characterized by immune dysregulation and variable disease activity.
  • Predicting clinical disease flares in SLE remains a challenge for proactive management.

Purpose of the Study:

  • To identify immune mediators that signal an impending SLE flare.
  • To refine a flare risk index (FRI) using these mediators for improved prediction of SLE flares.

Main Methods:

  • Analyzed plasma mediators in SLE patients experiencing imminent flares versus those without flares.
  • Utilized microfluidic immunoassays and random forest analysis to identify key mediators.
  • Applied logistic regression to develop a refined FRI based on 11 selected mediators.

Main Results:

  • Demographics, autoantibodies, and clinical scores did not differentiate pre-flare from pre-nonflare states.
  • 11 plasma mediators were identified as key predictors of imminent SLE flares.
  • The refined FRI achieved high sensitivity (97%) and specificity (98%) in predicting flares.

Conclusions:

  • Altered immune mediators accurately predict imminent SLE flares.
  • A molecularly informed FRI enhances the ability to identify at-risk SLE patients.
  • This approach supports proactive management strategies in clinical trials and patient care.